MedTrace Logo

Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol

NCT05681156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2025-01-29

No results posted yet for this study

Summary

Beta trial to evaluate the preliminary clinical performance of the Curian S. pneumo/Legionella assay for its use in the qualitative detection of Streptococcus pneumoniae and/or Legionella pneumophila serogroup 1 antigens in human urine specimens.

Conditions

  • Streptococcus Pneumoniae Infection
  • Legionella Pneumophila Serogroup 1 Infection

Interventions

OTHER

N/A- There is no intervention.

There is no intervention.

Sponsors & Collaborators

  • Meridian Bioscience, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-03-23
Completion
2023-09-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05681156 on ClinicalTrials.gov